Additional information
yellow light Powder
1225195-71-0
ACI-020204
73-.9-74.5
C26H40N2O5
460.59
Ambient
2-8°C
Antihypertensive
Pharmaceutical Impurity Standards
1-[4-[4-(2-hydroxy-3-isopropylaminopropoxy) benzyloxylmethyl] phenoxy]- 3-isopropylaminopropan-2-ol
(RS)-1-[4-[4-(2-Hydroxy-3-isopropylaminopropoxy)benzyloxylmethyl] phenoxy]-3-isopropylaminopropan-2-ol
Bisoprolol Ether Dimer Hydrochloride





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)
 
                    